Cellnex Telecom (CLNX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
7 Jan, 2026Executive summary
Achieved or exceeded all 2024 financial and operational targets, with revenues up 7.7% to €3.941 billion and adjusted EBITDA rising 8% to €3.25 billion, at the upper end of guidance.
Completed major asset disposals in Austria, Ireland, Edzcom, and Nordics, with proceeds supporting deleveraging and shareholder returns.
Announced and launched an €800 million share buyback program, with a commitment to a minimum €500 million annual dividend from 2026.
Secured new agreements and contract renegotiations in key markets, mitigating consolidation risks and extending strategic partnerships.
Maintained ESG leadership, with top ratings and inclusion in DJSI Europe and other sustainability indices.
Financial highlights
Revenues (ex pass-through) reached €3.941 billion, up 7.7% year-over-year, with organic growth at 7.3%.
Adjusted EBITDA rose 8% to €3.25 billion, with margin stable at 82%.
RLFCF increased 16.2% to €1.796 billion, exceeding targets; FCF more than doubled to €328 million.
Net profit impacted by €291 million net impairment related to Austria and higher amortization/financial costs.
CapEx reduced by €200 million year-over-year, with efficiency CapEx accelerating.
Outlook and guidance
2025 guidance (post-divestments): revenues €3.95–4.05 billion, adjusted EBITDA €3.275–3.375 billion, RLFCF €1.9–1.95 billion, FCF €280–380 million.
2027 guidance: revenues €4.32–4.52 billion, adjusted EBITDA €3.64–3.84 billion, RLFCF €2–2.2 billion, FCF €1.03–1.23 billion.
Cumulative cash generation expected to exceed €7 billion from 2026–2030, supporting ongoing shareholder returns.
Shareholder return policy set as a floor, with potential for increases, independent of further disposals.
Latest events from Cellnex Telecom
- Net profit jumped to €136.5M, with €1.3B buybacks and strong revenue and margin growth.CLNX
Q4 202527 Feb 2026 - Revenue and EBITDA growth continued, but net loss widened on Austrian impairment; guidance reaffirmed.CLNX
Q2 20242 Feb 2026 - Revenue and profit growth, asset sales, and strong cash flow support strategic shift.CLNX
Q3 202415 Jan 2026 - Strong Q1 growth, portfolio streamlining, and robust buyback amid resilient sector outlook.CLNX
Q1 202518 Nov 2025 - Strong growth, margin gains, and EUR 1B shareholder returns reaffirm guidance and resilience.CLNX
Q3 20257 Nov 2025 - Solid H1 2025 growth, enhanced cash flow, and resilient long-term contracts drive outlook.CLNX
Q2 202531 Oct 2025